- ECG changes or K ≥6.5 → treat now: calcium gluconate 3 g IV (30 mL of 10%) over 5–10 min; repeat if ECG still abnormal.
- Shift: regular insulin 5–10 units IV + dextrose 25 g (skip dextrose if glucose >250). Check glucose hourly × 6 h.
- Albuterol 10–20 mg nebulized adds to insulin.
- Remove: loop diuretic (if making urine), SZC or patiromer, dialysis if anuric/refractory.
- Rule out pseudohyperkalemia (hemolysis, very high WBC/platelets) — but do not wait if the ECG is abnormal.
Pathophysiology in 60 seconds
⌄
- 98% of K is inside cells. Serum K reflects shifts as much as total body K.
- High K → resting membrane potential less negative → Na channels inactivate → slow conduction → peaked T → wide QRS → sine wave → VF/asystole.
- Calcium raises the threshold potential → restores the gap → protects the heart (does not lower K).
- Insulin and β₂-agonists push K into cells via Na/K-ATPase (works in ~15–30 min, lasts 4–6 h).
Diagnosis
⌄
Schematic drawing · 25 mm/s · 10 mm/mV · swipe ↔
The ECG is insensitive — a normal ECG does not mean safe. Bradycardia, junctional rhythm, and BBB can be the only clues.
Causes: CKD/AKI · drugs (ACEi/ARB/ARNI, MRA, trimethoprim, heparin, NSAIDs, calcineurin inhibitors, digoxin toxicity, succinylcholine) · DKA/insulin lack · tissue breakdown (rhabdo, tumor lysis, hemolysis) · type 4 RTA · adrenal insufficiency.
Management
⌄
| Step | Drug | Dose | Onset |
|---|---|---|---|
| Stabilize | Calcium gluconate | 3 g IV (30 mL 10%) over 5–10 min; repeat | 1–3 min |
| Calcium chloride | 1 g (10 mL 10%) central line (or arrest) | ||
| Shift | Regular insulin | 5 units IV (eGFR <30 or low weight) – 10 units | 15–30 min |
| Dextrose | 25 g (D50 50 mL), then D10 infusion if glucose low/normal | ||
| Albuterol | 10–20 mg nebulized | 30 min | |
| Sodium bicarbonate | Only with metabolic acidosis | Weak alone | |
| Remove | Furosemide | 40–80 mg IV (with fluids if not overloaded) | Hours |
| Sodium zirconium cyclosilicate | 10 g PO TID × 48 h | ~1 h | |
| Patiromer | 8.4 g daily | ~7 h | |
| Hemodialysis | Anuric, refractory, rhabdo/TLS | Fast |
Sodium polystyrene sulfonate (Kayexalate) — slow, weak, and linked to colonic necrosis. Prefer newer binders.
- Digoxin toxicity + hyperK → Digoxin Fab (calcium is probably safe but give Fab first).
- Long-term: low-K diet guidance, binders to keep life-saving RAAS inhibitors, loop/thiazide diuretics, fix acidosis.
Pitfalls
⌄
- Hypoglycemia after insulin (up to 6 h later, esp. CKD) — the most common harm.
- Rechecking K too early (10 min) and calling it "fixed" — shift is temporary.
- Forgetting the source (stop the trimethoprim, the spironolactone).
- Treating a hemolyzed sample with insulin in a well patient.
Board corner
⌄
| Stem | Answer |
|---|---|
| K 7.1, wide QRS | IV calcium first |
| Most important first step with peaked T waves | Calcium |
| Which therapy actually lowers total body K? | Binders, diuretics, dialysis |
| K 6.0 on TMP-SMX + lisinopril | Trimethoprim blocks ENaC (amiloride-like) |
| HyperK + hyponatremia + hypotension + hyperpigmentation | Adrenal insufficiency |
References
⌄
- UK Kidney Association. Clinical Practice Guideline: Treatment of Acute Hyperkalaemia in Adults. 2020 (update 2023).
- Palmer BF, Clegg DJ. Hyperkalemia across the continuum. JAMA. 2021.
- Clase CM, et al. KDIGO Controversies Conference on potassium. Kidney Int. 2020;97:42.